Neoplastic pericardial effusion: Efficacy and safety of intrapericardial treatment with cisplatin

European Heart Journal

Volumn 23, Issue 20, 2002, Pages 1625-1631

  Maisch, Bernhard ^a   Risti, A D ^a   Pankuweit, S ^a   Neubauer, A ^a   Moll, R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cisplatin; Pericardial effusion; Pericarditis; Pericardium; Tumours

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN C; PACLITAXEL; TAMOXIFEN; VINBLASTINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; ESOPHAGUS CARCINOMA; FEMALE; HEART MUSCLE ISCHEMIA; HODGKIN DISEASE; HUMAN; IMMUNOHISTOLOGY; LUNG CARCINOMA; MALE; MESOTHELIOMA; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASMS; PERICARDIAL EFFUSION; RECURRENCE;

EID: 0036797258     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3328     Document Type: Article

References (45)

1. Mukai K, Shinkai T, Tominaga K, Shimosatto Y. The incidence of secondary tumours of the heart and pericardium: A 10 year study. Jpn J Clin Oncol 1988; 18: 195-201.
2. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. Am J Med 1981; 71: 407-13.
3. Wilding G, Green HL, Longo DL, Urba WJ. Tumours of the heart and pericardium. Cancer Treat Rev 1988; 15: 165-81.
4. Spodick DH. Pericardial diseases. In: Braunwald E, Zipes DP, LibbyP, eds. Heart Disease, 6th Edn. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, W.B. Saunders; 2001: 1823-76.
5. Ziskind AA, Palacios IF. Percutaneous balloon pericardiotomy for patients with pericardial effusion and tamponade. In: Topol EJ, ed. Textbook of Interventional Cardiology, 3rd Edn. Philadelphia, W.B. Saunders; 1999: 869-77.
6. Ristić AD, Seferovié PM, Maksimović R, Ostojíc M. Percutaneous balloon pericardiotomy in neoplastic pericardial effusion. In Seferović PM, Spodick DH, Maisch B, eds. Pericardiology: Contemporary Answers to Continuing Challenges. Belgrade: Science; 2000: 427-38.
7. Aitini E, Cavazzini G, Pasquini E et al. Treatment of primary or metastatic pleural effusion with intracavitary cytosine arabinoside and cisplatin. A phase II study. Acta Oncol 1994; 33: 191-4.
8. Maisch B, Pankuweit S, Brilla C et al. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy - Results from a pilot study. Clin Cardiol 1999; 22(Suppl 1): 117-22.
9. Bindi M, Trusso M, Tucci E. Intracavitary cisplatin in malignant cardiac tamponade. Tumori 1987; 73: 163-5.
10. Pavon-Jimenez R, Garcia-Rubira JC, Garcia-Martinez JT et al. Intrapericardial cisplatin for malignant tamponade. Rev Esp Cardiol 2000; 53: 587-9.
11. Tomkowski W, Szturmowicz M, Fijalkowska A, Filipecki S, Figura-Chojak E. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol 1994; 120: 434-6.
12. Tomkowski WZ, Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer 1997; 16: 215-22.
13. Tomkowski WZ, Filipecki S. Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung. Arch Chest Dis 1997; 52: 221-4.
14. Tomkowski W, Szturmowicz M, Fijalkowska A Burakowski J, Filipecki S. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 1997; 5: 64-6.
15. Fiorentino MV, Daniele O, Morandi P et al. Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 1988; 62: 1904-6.
16. Tondini M, Rocco G, Bianchi C, Severi C, Corbellini D. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 1995; 50: 86-8.
17. Lestuzzi Ch, Viel E, Sorio R, Meneguzzo N. Local chemotherapy for neoplastic pericardial effusion [letter]. Am J Cardiol 2000; 86: 1292.
18. Beretta F, Martinelli G, Cavalli F, Marone C. Pericardial effusion in patients with malignant neoplasms. Schweiz Med Wochenschr 1992; 122: 1517-24.
19. Bishiniotis TS, Antoniadou S, Katseas G, Mouratidou D, Litos AG, Balamoutsos N. Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 2000; 86: 362-4.
20. Colleoni M, Martinelli G, Beretta F et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: An active and well-tolerated regimen. J Clin Oncol 1998; 16: 2371-6.
21. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: Effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997; 64: 1422-7.
22. Martinoni A, Cipolla CM, Civelli M et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000; 25: 787-93.
23. Fukuoka M, Takada M, Tamai S et al. Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion. Gan To Kagaku Ryoho 1984; 11: 1543-9.
24. Lee LN, Yang PC, Chang DB et al. Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax 1994; 49: 594-5.
25. Liu G, Crump M, Goss PE, Dancey J, Shepherd FA. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade J Clin Oncol 1996; 14: 3141-7.
26. van der Gaast A, Kok TC, van der Linden NH, Splinter TA. Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 1989; 25: 1505-6.
27. Yano T, Yokoyama H, Inoue T, Takanashi N, Asoh H, Ichinose Y. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994; 51: 507-9.
28. Cormican MC, Nyman CR. Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. Br Heart J 1990; 63: 61-2.
29. Davis S, Rambotti P, Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol 1984; 2: 631-6.
30. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996; 112: 637-43.
31. Salamon P, Berliner S, Shachner A, Pinkhas J. Tetracycline treatment for malignant pericardial effusion. Med Interne 1989; 27: 73-4.
32. Shepherd FA, Ginsberg JS, Evans WK, Scott JG, Oleksiuk F. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 1985; 3: 1678-82.
33. Shepherd FA, Morgan C, Evans WK, Ginsberg JF, Watt D, Murphy K. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987; 60: 1161-66.
34. Norum J, Lunde P, Aasebo U, Himmelmann A. Mitoxantrone in malignant pericardial effusion. J Chemother 1998; 10: 399-404.
35. Primrose WR, Clee MD, Johnston RN. Malignant pericardial effusion managed with Vinblastine. Clin Oncol 1983; 9: 67-70.
36. Dempke W, Firusian N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer 1999; 80: 1955-7.
37. Firusian N. 32P therapy of malignant pericardial effusions. Onkologie 1980; 3: 12-7.
38. Martini N, Freiman AH, Watson RC, Hilaris BS. Intrapericardial installation of radioactive chromic phosphate in malignant effusion. AJR Am J Roentgenol 1977; 128: 639-41.
39. Sprengelmeyer JT, McDermott RL. Phosphorus-32-colloidal chromic phosphate: Treatment of choice for malignant pericardial effusion. J Nucl Med 1990; 31: 2034-6.
40. Lissoni P, Barni S, Tancini G et al. Intracavitary therapy of neoplastic effusions with cytokines: Comparison among interferon alpha, beta and interleukin-2. Support Care Cancer 1995; 3: 78-80.
41. Imamura T, Tamura K, Takenaga M, Nagamoto Y, Ishikawa T, Nakagawa S. Intrapericardial OK-432 instillation for the management of malignant pericardial effusion. Cancer 1991; 68: 259-63.
42. Keane D, Jackson G. Managing recurrent malignant pericardial effusions. Br Med J 1992; 305: 729-30.
43. Tulleken JE, Kooiman CG, van der Werf TS, Zijlstra JG, de Vries EG. Constrictive pericarditis after high-dose chemotherapy. Lancet 1997; 350: 1601.
44. Kahles H, Bastian HJ, Schiffmann O, Geck M, Helmke FR, Golz N. Mitoxantrone-induced acute left heart failure after intrapleural administration. Herz 1997; 22: 217-20.
45. Seferovi6 PM, Risti6 AD, Maksimovi6 R et al. Treatment of neoplastic pericardial effusion: Percutaneous balloon pericardiotomy vs. prolonged subxiphoid drainage (abstr). Eur Heart J 2000; 21(Abstr Suppl): 418.